X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 58
PharmaCompass offers a list of Rislenemdaz API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rislenemdaz manufacturer or Rislenemdaz supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rislenemdaz manufacturer or Rislenemdaz supplier.
PharmaCompass also assists you with knowing the Rislenemdaz API Price utilized in the formulation of products. Rislenemdaz API Price is not always fixed or binding as the Rislenemdaz Price is obtained through a variety of data sources. The Rislenemdaz Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rislenemdaz manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rislenemdaz, including repackagers and relabelers. The FDA regulates Rislenemdaz manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rislenemdaz API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rislenemdaz supplier is an individual or a company that provides Rislenemdaz active pharmaceutical ingredient (API) or Rislenemdaz finished formulations upon request. The Rislenemdaz suppliers may include Rislenemdaz API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rislenemdaz as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rislenemdaz API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rislenemdaz as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rislenemdaz and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rislenemdaz NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rislenemdaz suppliers with NDC on PharmaCompass.
We have 1 companies offering Rislenemdaz
Get in contact with the supplier of your choice:
Market Place
